Form 4 Filing for Arcus Biosciences, Inc. (RCUS)

This filing details a Form 4 filed by Patrick Machado, a director at Arcus Biosciences, Inc. On June 11, 2026, Machado was granted 5,700 shares of Common Stock and 16,900 stock options. The restricted stock units (RSUs) and stock options vest fully on June 11, 2027, or the next annual stockholder meeting, and will also vest immediately upon a change in control of the company. The RSUs were granted with a transaction price of $0.00 and the stock options have an exercise price of $23.30. Post-transaction, Machado holds 44,300 shares of Common Stock and 16,900 stock options.